Dudediligence.

Rhythm Pharmaceuticals, Inc

RYTMNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$33.3MSep ’24$41.8MDec ’24$32.7MMar ’25$48.5MJun ’25$51.3MSep ’25$57.3MDec ’25$60.1MMar ’26$71.3MJun ’26
Net income, by quarter
−$43.6MSep ’24−$43.3MDec ’24−$49.5MMar ’25−$46.6MJun ’25−$52.9MSep ’25$148.8MDec ’25−$55.6MMar ’26−$49.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$3.2M$23.6M$77.4M$130.1M$189.8M
Gross profit$2.6M$21.5M$68.1M$116.8M$170.3M
Operating income−$170.1M−$179.2M−$184.4M−$265.5M−$192.0M
Net income−$69.6M−$181.1M−$184.7M−$260.6M−$196,539
Operating cash flow−$146.0M−$173.4M−$136.2M−$113.9M−$115.7M
Free cash flow−$146.4M−$173.7M−$136.2M−$113.9M−$116.6M
Cash$59.2M$127.7M$60.1M$89.1M$54.3M
Debtnone on filenone on file$106.1M$109.8M$108.2M
Shares outstanding50.3M56.6M59.4M62.4M67.2M